Nurix Therapeutics: Of This Current Report On Form 8k, Including Exhibits 99.1 And 99.2, Shall Not Be Deemed To Be “filed” For Purposes Of Section 18 Of The Securities Exchange Act Of 1934, As Amended (the “exchange Act”), Or Otherwise Subject To The Liability Of That Section, And Shall Not Be Incorporated By Reference Into Any Registration Statement Or Other Document Filed Under The Securities Act Of 1933, As Amended, Or The Exchange Act, Except As Shall Be Expressly Set Forth By Specific Reference In Such Filing. In Addition, The Information Set Forth Under This Item 7.01, Including Exhibits 99.1 And 99.2, Shall Not Be Deemed An Admission As To The Materiality Of Any Information In This Current Report On Form 8k, Financial Statements And Exhibits

Mostra articolo completo

Questa funzionalità è disponibile solo per gli utenti registrati

• Nome completo dell'emittente
  Nurix Therapeutics Inc
• Paese di registrazione
  USA
• Settore industriale
  Pharmaceutical Preparation and Biotechnology
• М/S&P/F
  *** / *** / ***